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 Abstract 
 Background: During acellular replacement of an acute blood loss, hyperoxic ventilation (HV) in-
creases the amount of O 2 physically dissolved in the plasma and thereby improves O 2 supply to 
the tissues. While this effect could be demonstrated for HV with inspiratory O 2 fraction (FiO 2 ) 0.6, 
it was unclear whether HV with pure oxygen (FiO 2 1.0) would have an additional effect on the 
physiological limit of acute normovolemic anemia.  Methods: Seven anesthetized domestic pigs 
were ventilated with FiO 2 1.0 and subjected to an isovolemic hemodilution protocol. Blood was 
drawn and replaced by a 6% hydroxyethyl starch (HES) solution (130/0.4) until a sudden decrease 
of total body O 2 consumption (VO 2 ) indicated the onset of O 2 supply dependency (primary end-
point). The corresponding hemoglobin (Hb) concentration was defined as ‘critical Hb’ (Hb crit ). 
Secondary endpoints were parameters of myocardial function, central hemodynamics, O 2 trans-
port and tissue oxygenation.  Results: HV with FiO 2 1.0 enabled a large blood-for-HES exchange 
(156 ± 28% of the circulating blood volume) until Hb crit was met at 1.3 ± 0.3 g/dl. After termina-
tion of the hemodilution protocol, the contribution of O 2 physically dissolved in the plasma to O 2 
delivery and VO 2 had significantly increased from 11.7 ± 2 to 44.2 ± 9.7% and from 29.1 ± 4.2 to 
66.2 ± 11.7%, respectively. However, at Hb crit , cardiovascular performance was found to have se-
verely deteriorated.  Conclusion: HV with FiO 2 1.0 maintains O 2 supply to tissues during extensive 
blood-for-HES exchange. In acute situations, where profound anemia must be tolerated (e.g. 
bridging an acute blood loss until red blood cells become available for transfusion), O 2 physi-
cally dissolved in the plasma becomes an essential source of oxygen. However, compromised 
cardiovascular performance might require additional treatment.  © 2013 S. Karger AG, Basel 
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 Introduction 
 The initial treatment of an acute blood loss usually consists in the infusion of crystalloid 
and/or colloidal fluids. However, the restoration of normovolemia with acellular fluids leads 
to a dilution of the red cell mass remaining in the vasculature (acute normovolemic anemia). 
In this context, the term ‘anemia tolerance’ refers both to the patient’s physiological condition 
to tolerate acute anemia and the physician’s readiness to accept low hemoglobin (Hb) values 
(e.g. during restrictive transfusion regimes)  [1] .
 Although O 2 transport capacity decreases progressively with hemodilution, tissue 
oxygenation can be sustained over a wide range of decreasing Hb concentrations  [2] . First, 
acute normovolemic anemia is compensated by increases in cardiac output and arterio-
venous O 2 extraction (O 2 ER)  [3] so that O 2 delivery (DO 2 ) to the tissues and O 2 consumption 
(VO 2 ) remain constant. Second, at physiologic Hb concentrations, DO 2 exceeds VO 2 by the 
factor 3–4  [4] . Therefore, O 2 supply to the tissues is still sufficient to meet their O 2 demand 
even when DO 2 begins to decrease at lower Hb concentrations (supply independency of VO 2 ; 
 fig. 1 ). 
 When DO 2 falls below the value of VO 2 , O 2 metabolism becomes dependent on DO 2 and 
VO 2 starts to decline (supply dependency of VO 2  [5, 6] ). The Hb concentration corresponding 
to the sudden decrease in VO 2 is called ‘critical Hb’ (Hb crit ) and reflects the individual limit of 
anemia tolerance  [1] .
 Hyperoxic ventilation (HV) provides a simple but effective possibility to improve O 2 
supply to the tissues, when the number of circulating red blood cells becomes insufficient 
to meet total-body O 2 demand. In a previous study, we could already demonstrate that the 
institution of HV with inspiratory O 2 fraction (FiO 2 ) 0.6 prior to induction of acute normo-
volemic anemia allowed for hemodilution to lower values of Hb crit than did ventilation with 
ambient air  [7] . However, the question remained open whether using pure oxygen could 
additionally increase anemia tolerance. We therefore hypothesized that HV with FiO 2 1.0 
allows for a more extensive hemodilution, even resulting in a lower value of Hb crit than HV 
with FiO 2 0.6.
 Materials and Methods 
 With the approval of the governmental review board (approval code V54-19c 20/15-91/30), experi-
ments were performed in 7 healthy farm-bred pigs of either sex (body weight 29.8 ± 3.7 kg). All animals 
received good care in compliance with the  Guide for the Care and Use of Laboratory Animals .
 Anesthesia and Ventilation 
 Twelve hours before the experiments, the animals were denied food but had free access to water. After 
i.m. premedication with 10 mg/kg ketamine and 1 mg/kg midazolam, anesthesia was induced by i.v. injection 
of fentanyl (20 μg/kg) and propofol (1.5 mg/kg) and maintained by continuous infusion of midazolam (0.01 
mg/kg/min), propofol (0.16 mg/kg/min) and fentanyl (0.8 μg/kg/min). To facilitate intubation, animals 
were paralyzed by a bolus injection of pancuronium (0.2 mg/kg). For adequate assessment of oxygen tension 
(tpO 2 ) on the surface of a skeletal muscle (see below), neuromuscular blockade (NMB) was maintained by 
continuous infusion of pancuronium (0.12 mg/min). Estimated fluid losses (particularly including insensible 
perspiration owing to the open-chest model, see below) were replaced by a balanced electrolyte solution 
(0.25 ml/kg/min). All trade names of anesthetics and infusion fluids used are listed in the Appendix. 
 After orotracheal intubation, animals were ventilated using the CMV mode (controlled mandatory venti-
lation; 12 cycles/min, PEEP 5 cm H 2 O; Vela Ventilator, Viasys Healthcare, Höchberg, Germany). Based on 
repeated blood gas analyses, tidal volume was adjusted to provide arterial normocapnia and was then main-
tained throughout the entire protocol. Until the end of surgical preparation, all animals were ventilated with 
ambient air.
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 Instrumentation and Monitoring 
 All animals were placed in supine position. A 5-lead electrocardiogram (II, V5) was installed for detection 
of arrhythmias and ST segment changes. Animals were instrumented with 2 electronic tip manometer cath-
eters (PC 370, Millar Instruments, Houston, Tex., USA) placed in the abdominal part of the aorta and in the 
left ventricle. A double-lumen catheter (Arrow, Reading, Pa., USA) was inserted into the superior vena cava, 
and a Swan-Ganz catheter (right ventricular ejection fraction/volumetric catheter, Baxter, Irvine, Calif., USA) 
was floated into a branch of the pulmonary artery. After midline sternotomy and opening of the pericardium, 
an ultrasonic flow probe (diameter 14 mm; Transonic Systems, Ithaca, N.Y., USA) was placed around the root 
of the aorta for continuous measurement of cardiac output. The left anterior descending coronary artery 
(LAD) was dissected free from surrounding tissue, and an additional ultrasonic flow probe (diameter 2 mm; 
Transonic Systems) was implanted for assessment of coronary blood flow. For withdrawal of coronary 
venous blood samples, the anterior interventricular vein was cannulated with an 18-gauge Teflon catheter 
(Leader Cath, Vygon, Ecouen, France). A large-bore hemodialysis catheter and a 7-French introducer sheath 
(both by Arrow) were inserted into the left femoral vein and into the right femoral artery for withdrawal of 
blood and isovolemic infusion of hydroxyethyl starch (HES), respectively. Via a mini-laparotomy, a Foley 
catheter (Rüsch, Kernen, Germany) was inserted into the urinary bladder. An area of 3 × 5 cm of the anterior 
rectus abdominis muscle was dissected free from surrounding tissue for measurement of tpO 2 . Body temper-
ature was kept constant using a warming pad and a warming lamp.
 Experimental Protocol 
 After completion of surgical preparation and installation of the different measuring devices, FiO 2 was 
increased to 1.0 and a new calibration of the Oxycon Pro TM device (Viasys Healthcare) was performed with 
pure oxygen. Subsequently, a 60-min stabilization period was allowed to elapse to achieve stable baseline 
conditions. 
 The baseline data set was recorded, and subsequently, acute normovolemic anemia was induced by 
simultaneous exchange of blood for 6% tetrastarch (HES 130/0.4, exchange rate 1 ml/kg/min). The target 
parameter was the animal’s individual Hb crit . When this target was met, a second set of data was collected. 
Subsequently, animals were killed by intracardial injection of saturated potassium solution. 
 Determination of Hb crit 
 Hb crit is the correlate of the critical limitation of DO 2 and marks the onset of total body O 2 supply depen-
dency ( fig. 1 ). The corresponding decrease of VO 2 was detected in an automated and investigator-inde-
pendent manner: VO 2 was measured with an ergospirometer (Oxycon Pro). VO 2 values were recorded and 
computed with a specific software (DeltaCrit System, DCS)  [8] . During the stabilization period, DCS includes 
VO 2 values into an online regression analysis and calculates mean and third standard deviation (SD). During 
DO2crit
(Hbcrit)
VO
2
DO2
DO2 dependency
of VO2
DO2 independency
of VO2
Hypoxia
 Fig. 1. Relationship between VO 2 
and DO 2 . Physiologically, DO 2 
amounts to 3- to 4-fold of VO 2 . 
Over a long period, VO 2 remains 
independent of DO 2 despite the 
anemia-related decrease of DO 2 . 
When Hb crit is reached, DO 2 falls 
short of the actual O 2 demand and 
VO 2 begins to decrease (onset of 
O 2 supply dependency of VO 2 ). 
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the subsequent hemodilution period, every VO 2 value is compared to the mean value predicted by DCS. When 
3 subsequent VO 2 values are outside the predefined range (3 × SD of regression line), a significant decrease 
of VO 2 is assumed and indicated by a visual and acoustic computer alert  [8] . A typical VO 2 recording is 
depicted in  figure 2 .
 Measurements 
 Blood volume was determined at baseline and at the individual Hb crit (Hb crit -1.0) using the ‘whole-blood’ 
method of the indocyanine green indicator dilution technique, which has already been described in detail 
elsewhere  [9] . The pressure transducers and flowmeters of the hemodynamic measurement devices were 
connected with a multichannel recorder (Hugo Sachs, March-Hugstetten, Germany) and measurement 
readings were recorded with a personal computer. The indices of cardiac output (cardiac index, CI) and 
systemic vascular resistance index (SVRI) as well as pulmonary vascular resistance index (PVRI) were calcu-
lated relative to body surface area (see Appendix). 
 Arterial, mixed venous and coronary venous blood samples were drawn at baseline and at Hb crit -1.0 for 
blood gas analysis (ABL 300, Radiometer, Copenhagen, Denmark) and assessment of Hb concentration (682 
CO-Oximeter, Instrumentation Laboratory, Lexington, Mass., USA). 
 During the hemodilution period, arterial and mixed venous blood samples were drawn after every 200 
ml of blood exchange. Hemodynamic parameters were registered continuously with the laboratory setup.
 For comparison with the results of our previous study, 2 additional data sets corresponding to Hb  ∼ 2.4 
g/dl (Hb crit -0.21, i.e. Hb crit in animals ventilated with FiO 2 0.21) and Hb  ∼ 1.6 g/dl (Hb crit -0.6, i.e. Hb crit in 
animals ventilated with FiO 2 0.6) were retrospectively read out from the continuous recordings. 
 tpO 2 on the surface of the skeletal muscle was determined at baseline and at Hb crit -1.0 using 2 multiwire 
platinum surface electrodes (MDO-Electrode, Eschweiler, Kiel, Germany) connected with a microprocessor 
system (Ingenieurbüro Mussler, Aachen, Germany). After equilibration with the tissue surface, this method 
enables exact assessment of tpO 2  [10] . With each measurement, 240 individual tpO 2 values were recorded; 
the location of the electrodes on the muscle surface was changed 3–5 times each.
 Statistics 
 Statistical analysis was performed using the SAS 9.2 software package (SAS Institute, Cary, N.C., USA). 
All data are presented as means ± SD. Data distribution was assessed using Shapiro-Wilk test. 
 In case of normal distribution, time effects on the different variables were tested by repeated analysis 
of variance (ANOVA). Post hoc analysis of differences detected with ANOVA was performed with the Student-
Newman-Keuls test. In case of nonnormal distribution, time effects on the parameters were tested by analysis 
of variance on ranks (rANOVA). Post hoc analysis of differences detected with rANOVA was performed with 
Tukey’s test. 
450100 150 200 250 300 350 400
Time (min)
250
200
150
100
50
0
VO
2 
(m
l/m
in
)
Stabilization Hemodilution
2Ĳ 3Ĳ
Hbcrit 
 Fig. 2. Typical example of VO 2 re-
cording in the course of the exper-
imental protocol. A linear regres-
sion analysis including the calcu-
lation of SD was performed with 
VO 2 values collected during the 
60-min stabilization period. Dur-
ing the subsequent hemodilution 
protocol, a critical limitation of 
DO 2 was assumed when 3 consec-
utive VO 2 values fell below the 
lower 3σ range. 
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 Statistical analysis of the parameter ‘tpO 2 ’ was performed by a paired t test analysis of the medians of 
the single tpO 2 values obtained per observation (see above). 
 For all parameters, statistical significance was accepted at p < 0.05. 
 Results  
 Primary Endpoint: Hb crit 
 Hemodilution to Hb crit -1.0 required the exchange of 3,749 ± 640 ml of blood for HES, 
corresponding with an exchange of 156 ± 28% of the circulating blood volume. Beginning 
with a Hb concentration of 7.7 ± 0.5 g/dl at baseline, Hb crit -1.0 was met at 1.3 ± 0.3 g/dl 
( fig. 3 ).
 Secondary Endpoints: Hemodynamic and O 2 -Derived Parameters 
 Table 1 displays secondary endpoint parameters at baseline, after hemodilution to Hb 
2.4 g/dl (i.e. Hb crit -0.21) and Hb 1.6 g/dl (i.e. Hb crit -0.6), and finally at the critical Hb concen-
tration (Hb crit -1.0). 
 Hemodynamics and Myocardial Function 
 During hemodilution to Hb 2.4 g/dl, heart rate (HR) increased by 27% and increased by 
a further 36% during hemodilution to Hb 1.5 g/dl. At Hb crit -1.0, HR decreased to baseline 
level. While mean pulmonary arterial pressure remained almost unchanged during the hemo-
dilution protocol, mean arterial pressure decreased continuously and was significantly 
beyond baseline level at Hb crit . Consistently, CI increased initially, while SVRI decreased by 
51% during hemodilution to Hb 2.4 g/dl, by 36% during hemodilution to Hb 1.5 g/dl and by 
a further 37% during the final hemodilution step.
 Left ventricular (LV) systolic contractility reflected by the maximal slope of LV pressure 
increase (dp/dt max ) increased at the beginning of the hemodilution protocol, but decreased 
under baseline level at Hb crit -1.0. Likewise, LV diastolic function represented by the maximum 
LV pressure decrease (dp/dt min ) had severely deteriorated at Hb crit -1.0.
2
H
b 
(g
/d
l)
4
6
8
Baseline Hbcrit
 Fig. 3. Hb concentrations at base-
line and at Hb crit . Beginning with a 
Hb concentration of 7.7 ± 0.5 g/dl 
at baseline, Hb crit was met at 1.3 ± 
0.3 g/dl. 
D
ow
nl
oa
de
d 
by
: 
UB
 d
er
 L
M
U 
M
ün
ch
en
   
   
   
   
   
   
   
   
   
   
   
   
 
12
9.
18
7.
25
4.
47
 - 
10
/2
0/
20
14
 2
:4
4:
23
 P
M
161Eur Surg Res 2013;51:156–169
 DOI: 10.1159/000357171 
 Pape et al.: The Limit of Anemia Tolerance during Hyperoxic Ventilation with Pure 
Oxygen in Anesthetized Domestic Pigs  
www.karger.com/esr
© 2013 S. Karger AG, Basel
 O 2 Transport and Tissue Oxygenation 
 Proportionally with the decrease in Hb concentration and arterial O 2 content (CaO 2 ), DO 2 
index decreased by 38% (hemodilution to Hb 2.4 g/dl), 37% (Hb 1.5 g/dl) and 36% (Hb crit -
1.0). As a compensation of acute anemia, arteriovenous O 2 ER increased with every hemodi-
lution step, which was accompanied by a slight but constant decrease of mixed venous O 2 
partial pressure (pvO 2 ).
 Hemodilution markedly decreased the contribution of Hb-transported O 2 to DO 2 and 
VO 2 . Simultaneously, the contribution of physically dissolved O 2 to DO 2 increased from 11.7 
± 2% (baseline) to 44.2 ± 9.7% (Hb crit ; p < 0.05) and its contribution to VO 2 increased from 
29.1 ± 4.3 to 66.2 ± 11.7% (p < 0.05;  fig. 4 a, b).
 Despite the utilization of physically dissolved O 2 , lactate concentration was elevated 
above baseline level at Hb 1.5 g/dl (p < 0.05) and further increased after continuation of 
Table 1.  Hemodynamic and O2-derived parameters assessed in animals ventilated with FiO2 1.0
Param eter Baseline Hbcrit-0.21 Hbcrit-0.6 Hbcrit-1.0
Hb, g/dl   7.7 ± 0.5   2.4 ± 0.5*   1.6 ± 0.4*, §   1.3 ± 0.3*, §
BVI, m/m2 81 ± 8 n.d. n.d. 79 ± 38
HR, l/min 74 ± 9 94 ± 17* 101 ± 20* 85 ± 16
MAP, mm Hg 91 ± 18 78 ± 31 57 ± 28*, § 34 ± 6*, §, #
MPAP, mm Hg 23 ± 3 25 ± 4 23 ± 3 21 ± 4§
CI, l/min/m2   3.3 ± 0.3   4.7 ± 0.4*   4.6 ± 1.0*   3.7 ± 1.2
SVI, ml/m2 45 ± 5 51 ± 9 46 ± 9 44 ± 9
SVRI, dyn•s/cm5/m2 2,352 ± 556 1,172 ± 464 755 ± 345* 482 ± 110*, §
PVRI, dyn•s/cm5/m2 304 ± 111 163 ± 158 159 ± 211 164 ± 224
LVP, mm Hg 107 ± 20 98 ± 29 78 ± 24* 59 ± 6*, §
LVEDP, mm Hg 10 ± 2 16 ± 5 15 ± 9 14 ± 5
dp/dtmax, mm Hg/s 2,258 ± 796 2,850 ± 2,471 2,638 ± 2,607 1,178 ± 462
dp/dtmin, mm Hg/s –3,372 ± 835 –3,003 ± 1,821 –2,265 ± 2,587 –863 ± 350*
VO2I, ml/m2/min 154 ± 16 135 ± 16 131 ± 18 140 ± 15
DO2I, ml/m2/min 374 ± 43 233 ± 28* 148 ± 27*, § 110 ± 32*, §, #
CaO2, ml/dl   11.4 ± 0.7   4.9 ± 0.5*   3.2 ± 0.2*, §   3.0 ± 0.2*, §
O2ER, % 36 ± 3 45 ± 4* 55 ± 1*, § 60 ± 4*, §, #
paO2, mm Hg 432 ± 78 397 ± 41 389 ± 50 418 ± 64
pvO2, mm Hg 44 ± 2 42 ± 4 40 ± 3 38 ± 3*
pH   7.45 ± 0.02   7.41 ± 0.07   7.37 ± 0.07   7.35 ± 0.07*
paCO2, mm Hg 39 ± 4 40 ± 5 38 ± 4 38 ± 5
HCO3, mm Hg 26 ± 2 24 ± 2* 21 ± 2*, § 21 ± 1*, §
BE, mmol/l   3.3 ± 1.5   0.3 ± 3.0   2.9 ± 2.7*   3.9 ± 2.5*, §
Lactate, mmol/l   0.9 ± 0.2   0.8 ± 0.2   1.7 ± 0.8*, §   2.2 ± 0.9*, §
CPP, mm Hg 59 ± 21 41 ± 29* 23 ± 24*, § 9 ± 7*, §
LAD flow, ml/min 44 ± 13 123 ± 44* 120 ± 49* 78 ± 27*, §, #
mDO2, ml/min 509 ± 164 626 ± 267 382 ± 150§ 230 ± 76*, §
mVO2, ml/min 367 ± 119 n.d. n.d. 153 ± 64*
mO2ER, % 72 ± 6 n.d. n.d. 66 ± 16
cv lactate, mmol/l   0.6 ± 0.2 n.d. n.d.   2.2 ± 0.8
 BVI = Blood volume indexed to body surface area; MAP = mean aortic pressure; MPAP = mean pulmonary 
arterial pressure; SVI = stroke volume index; LVP = left ventricular pressure; LVEDP = left ventricular 
end-diastolic pressure; VO2I and DO2I = indices of VO2 and DO2; paO2 and pvO2 = arterial and mixed venous 
O2 partial pressures; paCO2 = arterial carbon dioxide partial pressure; HCO3 = arterial bicarbonate 
concentration; BE = base excess; lactate = lactate concentration; mDO2 and mVO2 = DO2 and VO2 of 
LAD-supplied myocardium; mO2ER = myocardial O2ER; cv lactate = coronary venous lactate concentration.
* p < 0.05 vs. baseline; § p < 0.05 vs. Hbcrit-0.21; # p < 0.05 vs. Hbcrit-0.6.
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 Fig. 5. Sum histograms of all tpO 2 
values obtained on the surface of 
a skeletal muscle at baseline (bot-
tom) and at Hb crit (top). x-axis: 
tpO 2 values are displayed in class-
es of 5 mm Hg. y-axis: relative fre-
quency of tpO 2 values. At Hb crit , 
the histogram is left shifted, indi-
cating that the relative frequency 
of low tpO 2 values had increased: 
the median of the tpO 2 values de-
creased from 33.8 ± 12.1 to 8 ± 6 
mm Hg (p < 0.05) and the rate of 
hypoxic values increased from 9 ± 
4 to 64 ± 33% (p < 0.05). 
 Fig. 4.  a Contribution of Hb-transported O 2 (black) and physically dissolved O 2 (gray) to DO 2 at baseline and 
at Hb crit . Each bar represents 1 animal. During hemodilution, the contribution of physically dissolved O 2 in-
creased from 11.7 ± 2 to 44.2 ± 9.7% (p < 0.05).  b Contribution of Hb-transported O 2 (black) and physically 
dissolved O 2 (gray) to VO 2 at baseline and at Hb crit . Each bar represents 1 animal. During hemodilution, the 
contribution of physically dissolved O 2 to VO 2 increased from 29.1 ± 4.3 to 66.2 ± 11.7% (p < 0.05).  
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hemodilution to Hb crit -1.0. Consistently, base excess decreased by 90% during the first 2 
hemodilution steps and by a further 34% during hemodilution from 1.5 g/dl to Hb crit .
 Manifest tissue hypoxia on the surface of the skeletal muscle was indicated by the typical 
left shift of tpO 2 sum histograms ( fig. 5 ). The median decreased from 33.8 ± 12.1 to 8 ± 6 mm 
Hg (p < 0.05) and the fraction of hypoxic values increased from 9 ± 4 to 64 ± 33% (p < 0.05).
 Myocardial Perfusion and Oxygenation  
 To compensate for increased myocardial O 2 demand, coronary blood flow in the LAD 
increased initially by 279% (hemodilution to Hb 2.4 g/dl) and had a tendency to decrease 
during hemodilution from Hb 1.5 g/dl to Hb crit -1.0.
 However, during the entire hemodilution protocol, LAD flow remained increased. Consis-
tently with the decrease of SVRI, coronary perfusion pressure (CPP) decreased continuously 
beyond baseline level. While DO 2 to the LAD-supplied myocardium (mDO 2 ) decreased contin-
uously, myocardial O 2 ER and VO 2 remained almost unaltered. However, coronary venous 
lactate concentration was significantly increased at Hb crit -1.0, indicating compromised 
myocardial lactate extraction and aerobic capacity.
 Discussion 
 The main result of the present study is that HV with FiO 2 1.0 only provided a marginal 
increase of anemia tolerance as compared to animals ventilated with FiO 2 0.6 in our previous 
study  [7] . This is indicated by a slightly lower value of Hb crit (1.3 ± 0.3 vs. 1.6 ± 0.4 g/dl) and 
a higher volume of blood exchanged for HES (3,749 ± 640 vs. 2,634 ± 407 ml). 
 Regarding secondary endpoints ( table 2 ), animals ventilated with pure oxygen appeared 
slightly superior to animals ventilated with FiO 2 0.6 regarding the following criteria: first, 
they presented less tachycardiac and less hypotensive at Hb crit -0.21. However, at their indi-
vidual Hb crit , cardiovascular performance was equally impaired. Second, the increase of 
lactate appeared attenuated and pvO 2 tended to be higher at any time point. Third, at Hb crit -
0.6, myocardial perfusion appeared less compromised.
 Proportionally with FiO 2 , HV increases the amount of O 2 physically dissolved in the 
plasma. This effect gains importance in profound anemia, as the contribution of red blood 
cells to O 2 transport is declining and the significance of the plasma compartment as an O 2 
reservoir is increasing. At the site of microcirculation, physically dissolved O 2 is utilized more 
readily than Hb-bound O 2 , since plasma and red blood cells are separated in such a manner 
that the inner vascular wall is covered with a plasma layer. During HV, the utilization of phys-
ically dissolved O 2 is additionally favored due to the elevated gradient of O 2 partial pressure 
to the interstitium  [11, 12] . The actual utilization of physically dissolved O 2 is reflected by our 
data, as HV with pure O 2 significantly increased the contribution of physically dissolved O 2 to 
DO 2 and VO 2 ( fig. 4 a, b).
 HV with FiO 2 1.0 did not result in a substantially lower Hb crit when compared to FiO 2 0.6 
(1.3 vs. 1.5 g/dl). However, the absolutely lowest values of Hb crit were observed in 2 animals 
ventilated with FiO 2 1.0, which met Hb crit at 0.8 g/dl. Moreover, a more extensive blood-for-
HES exchange was necessary for institution of Hb crit than in animals ventilated with FiO 2 0.6.
 Hb crit marks the ultimate limit of anemia tolerance  [5, 13] ; without further treatment (e.g. 
elevation of FiO 2 , transfusion of red blood cells or infusion of artificial O 2 carriers), hemodi-
lution to Hb crit is associated with 100% mortality  [14–16] . Hb crit therefore reflects the limit 
of anemia tolerance at the level of the whole organism by averaging VO 2 of all organs. However, 
this approach disregards the cellular and organ-specific level of anemia tolerance. A recent 
study investigated the limits of anemia tolerance of the heart, the brain, the kidneys, the liver, 
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Table 2. Hemodynamic and O2-derived parameters obtained in animals ventilated with ambient air (group 
0.21) or with FiO2 0.6 (group 0.6)
Parameter Group Baseline Hbcrit-0.21 Hbcrit-0.6
Hb, g/dl 0.21   7.6 ± 0.8   2.4 ± 0.5*
0.6   8.2 ± 0.7   2.7 ± 0.4*   1.6 ± 0.4*
HR, l/min 0.21 102 ± 20 138 ± 27
0.6 100 ± 13 129 ± 18 110 ± 35
MAP, mm Hg 0.21   98 ± 18   75 ± 23
0.6 107 ± 14   92 ± 23   35 ± 12*
MPAP, mm Hg 0.21   26 ± 6   22 ± 4
0.6   16 ± 5§   15 ± 7   17 ± 9
CI, l/min/m2 0.21   3.3 ± 0.3   5.4 ± 1.1*
0.6   3.5 ± 0.6   5.2 ± 0.6*   3.7 ± 1.7
SVI, ml/m2 0.21   33 ± 5   39 ± 5
0.6   35 ± 7   41 ± 5   34 ± 12
SVRI, dyn•s/cm5/m2 0.21 2,195 ± 520 929 ± 235*
0.6 2,452 ± 380 1,419 ± 477*, § 933 ± 263
PVRI, dyn•s/cm5/m2 0.21 246 ± 229   11 ± 165
0.6 262 ± 117 157 ± 96 113 ± 146
LVP, mm Hg 0.21   98 ± 26   83 ± 29*
0.6 121 ± 24 110 ± 19   60 ± 15*
LVEDP, mm Hg 0.21   11 ± 7   21 ± 8
0.6   4 ± 2§   5 ± 3*, §   12 ± 5*
dp/dtmax, mm Hg/s 0.21 2,011 ± 1,132 1,896 ± 3,786§
0.6 2,698 ± 1,554 3,119 ± 1,815 1,790 ± 741
dp/dtmin, mm Hg/s 0.21 –2,817 ± 1,176 –2,568 ± 1,299
0.6 –3,152 ± 1,076 –2,838 ± 1,395 –1,383 ± 1,001
VO2I, ml/m2/min 0.21 190 ± 40 162 ± 34
0.6 224 ± 21 215 ± 21§ 150 ± 46*
DO2I, ml/m2/min 0.21 331 ± 43 191 ± 60*
0.6 400 ± 69 231 ± 44* 108 ± 43*
paO2, mm Hg 0.21   97 ± 6 116 ± 16
0.6 272 ± 21§ 279 ± 26§ 279 ± 46
CaO2, ml/dl 0.21   10 ± 1   3.5 ± 0.6*
0.6   12 ± 0.9§   4.4 ± 0.5*, §   3.0 ± 0.4*
pvO2, mm Hg 0.21   32 ± 4   25 ± 2*
0.6   43 ± 12§   33 ± 5§   31 ± 7
O2ER, % 0.21   47 ± 13   50 ± 13
0.6   40 ± 11   49 ± 11   52 ± 14
pH 0.21   7.48 ± 0.03   7.43 ± 0.05
0.6   7.35 ± 0.03   7.44 ± 0.04   7.38 ± 0.08
BE, mmol/l 0.21   3.8 ± 1.4   0.0 ± 2.4
0.6   4.0 ± 1.3   2.4 ± 1.5  – 2.1 ± 2.7
Lactate, mmol/l 0.21   2.2 ± 1.1   2.8 ± 1.3
0.6   1.2 ± 0.4   1.1 ± 0.4§   3.2 ± 1.4*
CPP, mm Hg 0.21   69 ± 15   39 ± 23
0.6   81 ± 13   56 ± 15§ 10 ± 10*
LAD flow, ml/min 0.21   54 ± 15 181 ± 65*
0.6   47 ± 20 138 ± 100*   99 ± 44
mDO2, ml/min 0.21 540 ± 155 634 ± 259
0.6 541 ± 209 622 ± 478 309 ± 149
cv lactate, mmol/l 0.21   1.8 ± 0.8   2.8 ± 1.7*
0.6   0.7 ± 0.2   4.2 ± 1.9*
Data excerpted from our previous study [7]. For abbreviations, see text and table 1. * p < 0.05 vs. baseline; 
§ p < 0.05 vs. group 0.21.
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the small intestine and the skeletal muscle. Especially in the kidneys and in the skeletal 
muscle, signs of tissue hypoxia were observed before the critical limit of systemic O 2 supply 
was reached  [17] .
 Although neglecting the organ-specific level of anemia tolerance may be judged as a limi-
tation of the present experimental model, the assessment of total-body Hb crit has been used 
in several experimental hemodilution studies. In particular, a reduction of Hb crit could be 
achieved by hypothermia (moderate reduction of body core temperature reduces total body 
O 2 demand  [18] ), infusion of norepinephrine (stabilization of CPP during hemodilution  [19] ), 
infusion of artificial O 2 carriers (maintenance of CaO 2 despite reduced hematocrit  [20, 21] ) 
and continuous NMB (lowering skeletal muscular O 2 demand  [22] ). 
 Notably, in paralyzed animals, Hb crit was found about 1 g/dl lower than in animals without 
NMB. NMB was used in the present study as well as in our previous study  [7] to eliminate 
muscular activity and thereby to enable exact performance of tpO 2 measurement. 
 Moreover, the choice of the infusion fluid used for hemodilution has an impact on Hb crit . 
While the use of HES in the clinical setting is presently a matter of controversy, mid-molecular 
HES preparations have at least in the experimental setting proven effective regarding the 
maintenance of tissue oxygenation in profound anemia and were in this respect superior to 
gelatin or to crystalloids  [23] . The advantages of HES 130/0.4 were explained with a lower 
degree of extravasation resulting in a more sustained volume effect and reduced tissue edema 
formation. 
 Hemodilution and hyperoxia have antipodal effects on microvascular resistance. Accel-
erated blood flow increases shear stress at the endothelial vascular layer, resulting in the 
release of nitrous oxide and vasodilation  [24, 25] . These effects are, however, counteracted 
by hyperoxic vasoconstriction, which has been observed in large vessels as well as in 
microvessels (arterioles, venules)  [26, 27] . While these effects are balanced at moderate 
degrees of anemia, stages of profound anemia are characterized by hypotension. When blood 
viscosity and, thus, intracapillary blood pressure fall below the hydrostatic pressure of the 
capillary-surrounding tissue, microvascular collapse is imminent  [28, 29] . 
 In the present study, microvascular collapse is indicated by the extreme left shift of the 
tpO 2 histograms, which occurred despite the significant portion of physically dissolved O 2 to 
O 2 supply. Impaired microvascular perfusion is also reflected by global indicators of tissue 
hypoxia (decreasing base excess and pH, increasing lactate concentration). As single organs 
have not been investigated in the present study, it is neither possible to localize potential 
origins of lactate production, nor to distinguish the degree of tissue hypoxia within particular 
organs. 
 Moreover, at their individual Hb crit , animals subjected to HV were more hypotensive than 
animals ventilated with ambient air. At extremely low Hb concentrations, myocardial oxygen-
ation became compromised by anemic hypoxia as well as by decreasing CPP. As a conse-
quence, cardiac output declines, resulting in a decrease of coronary blood flow and a further 
limitation of myocardial perfusion. 
 The onset of this vicious circle not only accelerates the breakdown of hemodynamic 
compensation, thereby directly decreasing VO 2 . This implies that at extremely low Hb levels, 
the primary endpoint of the experimental protocol is influenced by effects beyond limited O 2 
transport capacity, which should be judged as a weakness of our experimental model. 
However, at Hb crit -0.21, VO 2 was obviously not affected by circulatory failure, so that our main 
conclusion remains applicable, namely that HV with either FiO 2 increased anemia tolerance 
and therefore enabled continuation of hemodilution to Hb values below 2.4 g/dl (i.e. Hb crit -
0.21).
 The present study was motivated by the fact that in our previous study, FiO 2 had to be 
restricted to 0.6 for methodological reasons; the endpoint of the hemodilution protocol (i.e. 
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the onset of O 2 supply dependency of VO 2 ) was assessed with a Deltatrac TM II metabolic 
monitor (Datex-Engström, Helsinki, Finland)  [7] . This device calculates VO 2 as the quotient 
of CO 2 production (VCO 2 ) and the respiratory quotient (RQ), the latter being calculated with 
the Haldane transformation (see Appendix). As this algorithm yields implausible results 
when FiO 2 exceeds a maximum of 0.65, the institution of FiO 2 1.0 is impossible using the 
Deltatrac II metabolic monitor  [30] . Therefore, the question remained open whether a further 
increase of FiO 2 from 0.6 to 1.0 would additionally increase the tolerance of acute normo-
volemic anemia.
 At a later time point, the Oxycon Pro device became available. The algorithm of this device 
is based on the measurement of expiratory O 2 and CO 2 fractions with a paramagnetic and an 
infrared absorption sensor, respectively. According to the manual, the accuracy of 
measurement is 3% or 0.05 l/min, respectively. However, the Oxycon Pro device exerts a 
modified Haldane transformation, which allows assessment of VO 2 even during HV with pure 
oxygen, providing that the system has been calibrated with FiO 2 1.0. Although this algorithm 
underwent an in-house validation by the manufacturer, it has neither been published in detail 
so far, nor has it been validated against other techniques (e.g. reverse Fick principle). While 
the validity and reliability of VO 2 assessment with the Oxycon Pro device has already been 
investigated under normoxic conditions  [31] , this device was used in a recently published 
study investigating the effects of HV (FiO 2 1.0) on VO 2 and RQ in healthy spontaneously 
breathing volunteers  [32] . 
 In the setting of experimental hemodilution, the Oxycon Pro device enabled us for the 
first time to assess VO 2 even during HV with pure oxygen. With respect to the number of 
experimental animals and for ethical reasons, we decided to only perform the present 7 
experiments and to use the results of the previous study in terms of 2 historical reference 
groups.
 Our data demonstrate that HV with pure O 2 only provides a marginal gain of anemia 
tolerance as compared with FiO 2 0.6. Overall, the extensive blood-for-HES exchange until the 
onset of O 2 supply dependency implies that HV allows to delay the transfusion of red blood 
cells, e.g. in case of bridging an acute blood loss until blood products become available. 
However, while the lack of O 2 carriers can be compensated by physically dissolved O 2 in 
extreme anemia (i.e. Hb concentrations <2 g/dl), O 2 transport becomes additionally impaired 
by cardiovascular collapse and microvascular perfusion disorders. Despite the excellent 
bioavailability of physically dissolved O 2 , the management of extreme normovolemic anemia 
might require a multimodal approach including the choice of the optimal infusion fluid, deep 
NMB and circulatory support with catecholamines  [1] . HV with FiO 2 1.0 might temporarily be 
useful; however, HV with FiO 2 0.6 has equipotent effects on maintaining O 2 supply to the 
tissues.
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 Appendix 
 Body surface area (BSA) was calculated according to Holt et al.  [33] :
 BSA = k    ·   BW 2/3 (m 2 ),
 where BW = body weight (in kg) and k = 9 (constant for the species pig). 
 CI was calculated as:
2 ,m
CO lCI
BSA
 ¬­ ­ ­ ®
 
 where CO = cardiac output. 
 Stroke volume index (SVI) was calculated as:
2 ,m
CI lSVI
HR
 ¬­ ­ ­ ®
 
 where HR = heart rate. 
 SVRI and PVRI were calculated as:
	 

5 2
79 9 dyn s
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MAP CVP .
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 respectively, where MAP = mean aortic pressure; CVP = central venous pressure; MPAP = mean pulmonary 
arterial pressure, and LVEDP = left ventricular end-diastolic pressure. 
 O 2 ER was calculated as follows:
	 
2 22
2
100 % ,
CaO CvO
O ER
CaO

   
 where CaO 2 and CvO 2 are arterial and mixed venous O 2 content. 
 The contribution of physically dissolved O 2 (physO 2 ) to DO 2 and to VO 2 was calculated as:
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DO CaO
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   
 respectively, where paO 2 = arterial oxygen partial pressure. 
 CPP was calculated as:
 CPP =  DAP –  LVEDP ,
 where DAP = diastolic aortic pressure. 
 Myocardial DO 2 (mDO 2 ) and myocardial VO 2 (mVO 2 ) were calculated for the LAD-supplied area:
 mDO 2 =  LAD    ·   CaO 2 
 mVO 2 =  LAD   ·   ( CaO 2 –  CcvO 2 ),
 where LAD = LAD blood flow. 
 For the same myocardial area, myocardial O 2 ER (mO 2 ER) ratio was calculated as:
	 
2 22
2
100 % .
CaO CcvO
mO ER
CaO

   
 For calculation of VO 2 , CO 2 production (VCO 2 ) is divided by the RQ, which is calculated by the Haldane 
transformation:
	 
 221
VCOVO
RQ

	 
 2
2 2
2
2
1
2 ,
FiO
RQ FiO FeO
FiO
FeCO

 

 where FeO 2 = expiratory O 2 fraction and FeCO 2 = expiratory CO 2 fraction. 
 For induction and maintenance of anesthesia, the following drugs were used: ketamine (Ketavet TM , 
Parke-Davis, Berlin, Germany); midazolam (Midazolam TM , Ratiopharm, Ulm, Germany); propofol (Brevi-
mytal TM , Braun, Bad Melsungen, Germany); fentanyl (Fentanyl TM , Janssen, Neuss, Germany); pancuronium 
(Pancuronium TM , Curamed, Karlsruhe, Germany); balanced electrolyte solution (Tutofusin TM , Pharmacia, 
Erlangen, Germany), and HES 130/0.4 (Voluven TM , Fresenius Kabi, Bad Homburg, Germany).
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